{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:52:41Z","timestamp":1793857961199,"version":"4.6.1"},"reference-count":18,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2005,12,13]],"date-time":"2005-12-13T00:00:00Z","timestamp":1134432000000},"content-version":"vor","delay-in-days":4486,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[1993,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Objective.<\/jats:italic> To explore the role of proinflammatory cytokines in giant cell arteritis (GCA) and polymyalgia rheumatica (PMR), two clinically related syndromes characterized by an intense acute\u2010phase reaction. In particular, to determine plasma concentrations of interleukin\u20106 (IL\u20106) and tumor necrosis factor \u03b1 (TNF\u03b1) and to correlate changes in plasma IL\u20106 levels with clinical symptoms during corticosteroid therapy.<\/jats:p><jats:p><jats:italic>Methods.<\/jats:italic> IL\u20106 and TNF\u03b1 concentrations were determined in plasma samples from patients with untreated PMR or GCA, and plasma IL\u20106 levels were monitored in patients receiving long\u2010term therapy (14 months) with corticosteroids. To identify IL\u20106\u2013producing cells, the polymerase chain reaction was used to detect IL\u20106 messenger RNA. In vitro production of IL\u20106 and IL\u20102 by peripheral blood mononuclear cells (PBMC) from treated and untreated patients was quantified using IL\u20106\u2013 and IL\u20102\u2013specific bioassay systems.<\/jats:p><jats:p><jats:italic>Results.<\/jats:italic> IL\u20106 concentrations were increased in PMR and GCA patients, whereas TNF\u03b1 concentrations were similar to those in normal donors. Administration of corticosteroids rapidly reduced the levels of circulating IL\u20106 but did not correct the underlying mechanism inducing the increased IL\u20106 production. In individual patients, changes in plasma IL\u20106 levels and clinical manifestations during prolonged therapy were closely correlated. Short\u2010term withdrawal of corticosteroids, even after several months of treatment, was followed by an immediate increase in plasma IL\u20106 concentrations. To identify the cellular source of plasma IL\u20106, PBMC from treated and untreated patients with PMR or GCA were analyzed for their ability to secrete IL\u20106 and the T cell\u2013specific cytokine IL\u20102. Polyclonal T cell stimulation caused a rapid release of IL\u20106, which was shown to be derived exclusively from CD14+ cells.<\/jats:p><jats:p><jats:italic>Conclusion.<\/jats:italic> Increased production of IL\u20106, but not TNF\u03b1, is a characteristic finding in patients with PMR or GCA. Corticosteroids rapidly suppress IL\u20106 production but do not correct the underlying mechanism inducing the increased IL\u20106 production. The close correlation of plasma IL\u20106 concentrations with clinical symptoms suggests a direct contribution of this cytokine to the disease manifestations and presents the possibility that monitoring IL\u20106 levels would be useful in making decisions on adjustment of corticosteroid dosage in individual patients.<\/jats:p>","DOI":"10.1002\/art.1780360913","type":"journal-article","created":{"date-parts":[[2007,2,15]],"date-time":"2007-02-15T01:08:23Z","timestamp":1171501703000},"page":"1286-1294","source":"Crossref","is-referenced-by-count":296,"title":["Correlation of interleukin\u20106 production and disease activity in polymyalgia rheumatica and giant cell arteritis"],"prefix":"10.1002","volume":"36","author":[{"given":"Niall E.","family":"Roche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Fulbright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette D.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene G.","family":"Hunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg J.","family":"Goronzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia M.","family":"Weyand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,12,13]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"389","article-title":"Clinical manifestations of giant cell arteritis","volume":"6","author":"Calamia K","year":"1980","journal-title":"Rheum Dis Clin North Am"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-88-2-162"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-97-5-672"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330804"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/29.6.456"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.20.7251"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3492764"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.07.040189.001045"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330810"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/324073a0"},{"issue":"9","key":"e_1_2_1_12_2","first-page":"S78","article-title":"Increased frequencies of IL\u20106 producing monocytes in polymyalgia rheumatica and giant cell arteritis (abstract)","volume":"35","author":"Wagner A","year":"1992","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1982.tb22124.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198411293112205"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1992.tb01411.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.59.070190.004031"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/330662a0"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830181122"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-82-5-613"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.1780360913","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.1780360913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T02:19:54Z","timestamp":1700705994000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.1780360913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1993,9]]}},"alternative-id":["10.1002\/art.1780360913"],"URL":"https:\/\/doi.org\/10.1002\/art.1780360913","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,9]]}}}